Cargando…

PPARγ is dispensable for clear cell renal cell carcinoma progression

OBJECTIVE: Clear cell renal cell carcinoma (ccRCC) is a subtype of kidney cancer defined by robust lipid accumulation, which prior studies have indicated plays an important role in tumor progression. We hypothesized that the peroxisome proliferator-activated receptor gamma (PPARγ), detected in both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchez, Danielle J., Steger, David J., Skuli, Nicolas, Bansal, Ankita, Simon, M. Celeste
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034040/ https://www.ncbi.nlm.nih.gov/pubmed/29866440 http://dx.doi.org/10.1016/j.molmet.2018.05.013

Ejemplares similares

Glycogen metabolism is dispensable for tumor progression in clear cell renal cell carcinoma
por: Xie, Hong, et al.
Publicado: (2021)

G Protein γ subunit 7 loss contributes to progression of clear cell renal cell carcinoma
por: Xu, Shan, et al.
Publicado: (2019)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

A Double-Negative Feedback Interaction between miR-21 and PPAR-α in Clear Renal Cell Carcinoma
por: Goujon, Marine, et al.
Publicado: (2022)

PPARγ tackles treacherous T cells
por: Leslie, Mitch
Publicado: (2009)

Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma
por: Nie, Wenyuan, et al.
Publicado: (2022)

Cellular milieu in clear cell renal cell carcinoma
por: Raghubar, Arti M., et al.
Publicado: (2022)

PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis
por: Luo, Yongwen, et al.
Publicado: (2019)

Protective Actions of PPAR-γ Activation in Renal Endothelium
por: Westerweel, Peter E., et al.
Publicado: (2008)

Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells
por: Godfrey, Jason, et al.
Publicado: (2022)

Isoform-specific functions of PPARγ in gene regulation and metabolism
por: Hu, Wenxiang, et al.
Publicado: (2022)

Activation of PPARγ in Myeloid Cells Promotes Lung Cancer Progression and Metastasis
por: Li, Howard, et al.
Publicado: (2011)

Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis
por: Nemenoff, Raphael
Publicado: (2012)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)

Glutathione metabolism in cancer progression and treatment resistance
por: Bansal, Ankita, et al.
Publicado: (2018)

The role of PPARγ in prostate cancer development and progression
por: Hartley, Andrew, et al.
Publicado: (2022)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors
por: Kotlinowski, Jerzy, et al.
Publicado: (2014)

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
por: Yamashita, Masamichi
Publicado: (2008)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
por: Chiu, I-Jen, et al.
Publicado: (2020)

FBXL6 depletion restrains clear cell renal cell carcinoma progression
por: Yu, Yongchun, et al.
Publicado: (2022)

PPARγ maintains the metabolic heterogeneity and homeostasis of renal tubules
por: Lyu, Zhongshi, et al.
Publicado: (2018)

A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
por: Xu, Yingkun, et al.
Publicado: (2020)

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma
por: Andrejeva, Diana, et al.
Publicado: (2018)

Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy
por: Mao, Ruizhe, et al.
Publicado: (2021)

Erratum: PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors
por: Kotlinowski, Jerzy, et al.
Publicado: (2015)

PPARα-mediated peroxisome induction compensates PPARγ-deficiency in bronchiolar club cells
por: Karnati, Srikanth, et al.
Publicado: (2018)

Effect of ciRS-7 expression on clear cell renal cell carcinoma progression
por: Zhao, Yan-Hui, et al.
Publicado: (2020)

Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma
por: Huang, Yongqiang, et al.
Publicado: (2023)

Pathophysiological Roles of PPARγ in Gastrointestinal Epithelial Cells
por: Necela, Brian M., et al.
Publicado: (2008)

PPAR-γ Signaling Crosstalk in Mesenchymal Stem Cells
por: Takada, Ichiro, et al.
Publicado: (2010)

MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma
por: Neumann, Chase K.A., et al.
Publicado: (2020)

ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
por: Khare, Sanika, et al.
Publicado: (2021)

A Dominant-Negative PPARγ Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle Cells
por: Liu, Joey Z., et al.
Publicado: (2009)

Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006)

Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
por: Malaviya, Abhita, et al.
Publicado: (2014)

PD-L1 Mediates IFNγ-Regulation of Glucose but Not of Tryptophan Metabolism in Clear Cell Renal Cell Carcinoma
por: Garige, Mamatha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cfafdql83idu4kgp1mhvih02j3